Leave your feedback Share Copy URL https://gographicsoutput.com/video/IImupeYfWDw.html Email Facebook Twitter LinkedIn Pinterest Tumblr Share on Facebook Share on Twitter FDA reverses course, will review Moderna’s new mRNA flu vaccine [RiW866CE1jr] Health Updated on August 07, 2026 EDT — Published on August 07, 2026 EDT Two weeks ago, the FDA took the rare step of refusing to accept Moderna’s application for its first mRNA flu vaccine. After meeting with the company, the agency has now agreed to review it. gRjfE4U03KU VBjSIeJenYS 1hG9l7ehQES vLwKcMh2N8Q 4R2ArEmWdoN
Two weeks ago, the FDA took the rare step of refusing to accept Moderna’s application for its first mRNA flu vaccine. After meeting with the company, the agency has now agreed to review it. gRjfE4U03KU VBjSIeJenYS 1hG9l7ehQES vLwKcMh2N8Q 4R2ArEmWdoN